Atsushi Hatanaka, Sota Nakada, Gen Matsumoto, Katsuya Satoh, Iori Aketa, Akira Watanabe, Tomoaki Hirakawa, Tadayuki Tsujita, Tsuyoshi Waku, Akira Kobayashi. The transcription factor NRF1 (NFE2L1) activates aggrephagy by inducing p62 and GABARAPL1 after proteasome inhibition to maintain proteostasis. Scientific reports. 2023. 13. 1. 14405-14405
Shuuhei Hirose, Tsuyoshi Waku, Misato Tani, Haruka Masuda, Keiko Endo, Sanae Ashitani, Iori Aketa, Hina Kitano, Sota Nakada, Ayaka Wada, et al. NRF3 activates mTORC1 arginine-dependently for cancer cell viability. iScience. 2023. 26. 2. 106045-106045
Tsuyoshi Waku, Sota Nakada, Haruka Masuda, Haruna Sumi, Ayaka Wada, Shuuhei Hirose, Iori Aketa, Akira Kobayashi. The CNC-family transcription factor Nrf3 coordinates the melanogenesis cascade through macropinocytosis and autophagy regulation. Cell Reports. 2023. 42. 1. 111906
Tsuyoshi Waku, Takuya Iwami, Haruka Masuda, Shuuhei Hirose, Iori Aketa, Akira Kobayashi. Nrf3 Functions Reversely as a Tumorigenic to an Antitumorigenic Transcription Factor in Obese Mice. The Tohoku Journal of Experimental Medicine. 2023. 259. 1. 1-8
Tsuyoshi Waku, Akira Kobayashi. Pathophysiological Potentials of NRF3-Regulated Transcriptional Axes in Protein and Lipid Homeostasis. International Journal of Molecular Sciences. 2021. 22. 23. 12686-12686
NRF3 acts as a tumorigenic transcription factor for the assembly of a ubiquitin-independent 20S proteasome
(2019)
NRF3 (NFE2L3) contributes to colorectal cancer development through 20S proteasome assembly and the ubiquitinindependent proteolysis
(The Environmental Response V /17th JBS Biofrontier Symposium 2019)